Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-003131

Options or other derivatives

  • Chief Business Officer acquired 1,329,528 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TAYTON-MARTIN HELEN KATRINA Chief Business Officer 2021-01-11 Grant or award · Option to purchase Ordinary Shares +1,086,816 1,086,816 D
TAYTON-MARTIN HELEN KATRINA Chief Business Officer 2021-01-11 Grant or award · Option to purchase Ordinary Shares +242,712 242,712 D
Loading xslF345X03/tm212800-3_4seq1.xml…